Filing metadata

Accession number
0000935836-24-000317
Form type
Form 3
Filer
Adaptimmune Therapeutics PLC
CIK
CIK 1621227
Filed
Mar 26, 2024
Reporting period
Mar 08, 2024
Description
Initial ownership

Explore SEC Filings Hub